Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ...

We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are going to take a look at ...

Eli Lilly reports positive late-stage data for its weight-loss pill. BMO analyst says Lilly's update will weigh on shares of ...

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

With a market cap of $775.6 billion, Eli Lilly and Company (LLY ... Lilly’s shares jumped 3.4% on Feb. 6 after the company reported Q4 2024 adjusted EPS of $5.32 and revenue of $13.5 billion ...

With a market cap of $775.6 billion, Eli Lilly and Company (LLY) is a global biopharmaceutical leader with leading products ...

EPS of $1.15, compared to $1.01 in the prior-year quarter. Waste Management Inc. (NYSE:WM) (Q1) EPS of $1.66, compared to ...

We created this list by scanning Insider Monkey’s Q4 2024 database for US companies ... 218 percentage points (see more details here). Eli Lilly and Company (NYSE:LLY) ranks seventh on our ...

Next, we used Insider Monkey’s Q4 2024 proprietary hedge fund holdings ... beating its benchmark by 218 percentage points (see more details here). Eli Lilly and Company (NYSE:LLY) is a global ...

Sun Pharma is projected to lead in PAT growth at 28% YoY, while Cipla might see a 5% YoY decline, according to Centrum ...